Literature DB >> 16984877

Non-culture-based diagnostics for opportunistic fungi.

Monique A S H Mennink-Kersten1, Paul E Verweij.   

Abstract

The value of the diagnostic markers galactomannan and 1,3-beta-D-glucan for the diagnosis of opportunistic fungal infections is reviewed in this article. Both markers have undergone clinical evaluation, and increasing insight is emerging with respect to the causes of false-negative or false-positive reactivity. These data will help design protocols in which single or multiple markers are used to identify patients who require antifungal therapy.

Entities:  

Mesh:

Year:  2006        PMID: 16984877     DOI: 10.1016/j.idc.2006.06.009

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  17 in total

1.  High Levels of beta-D-glucan in immunocompromised children with proven invasive fungal disease.

Authors:  Alessandra Mularoni; Elisa Furfaro; Maura Faraci; Alessia Franceschi; Paola Mezzano; Roberto Bandettini; Claudio Viscoli; Elio Castagnola
Journal:  Clin Vaccine Immunol       Date:  2010-03-24

2.  Prospective study in critically ill non-neutropenic patients: diagnostic potential of (1,3)-β-D-glucan assay and circulating galactomannan for the diagnosis of invasive fungal disease.

Authors:  J Acosta; M Catalan; A del Palacio-Pérez-Medel; J-C Montejo; J De-La-Cruz-Bértolo; M-D Moragues; J Pontón; M A Finkelman; A del Palacio
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-08-03       Impact factor: 3.267

Review 3.  Invasive fungal infections in transplant recipients.

Authors:  Jose A Vazquez; Marisa H Miceli; George Alangaden
Journal:  Ther Adv Infect Dis       Date:  2013-06

Review 4.  Molecular and nonmolecular diagnostic methods for invasive fungal infections.

Authors:  Marios Arvanitis; Theodora Anagnostou; Beth Burgwyn Fuchs; Angela M Caliendo; Eleftherios Mylonakis
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

5.  Evaluation of a Novel Plasma (1,3)-β-d-Glucan Detection Assay for Diagnosis of Candidemia in Pediatric Patients.

Authors:  Ying Liu; Feng Chen; Xiaodong Zhu; Lisong Shen; Sean X Zhang
Journal:  J Clin Microbiol       Date:  2015-06-24       Impact factor: 5.948

6.  Serum galactomannan and (1->3)-β-D-glucan assays for patients with multiple myeloma and Waldenstrom's macroglobulinemia.

Authors:  Nicolas C Issa; Sophia Koo; Robert C Lynch; Charline Gay; Sarah P Hammond; Lindsey R Baden; Irene M Ghobrial; Malcolm A Finkelman; Francisco M Marty
Journal:  J Clin Microbiol       Date:  2011-12-14       Impact factor: 5.948

7.  Improved detection of circulating Aspergillus antigen by use of a modified pretreatment procedure.

Authors:  Monique A S H Mennink-Kersten; Dorien Ruegebrink; Rocus R Klont; Adilia Warris; Nicole M A Blijlevens; J Peter Donnelly; Paul E Verweij
Journal:  J Clin Microbiol       Date:  2008-02-20       Impact factor: 5.948

Review 8.  Antifungal management in cancer patients.

Authors:  Philipp Staber; Stefan Langner; Hans Jürgen Dornbusch; Peter Neumeister
Journal:  Wien Med Wochenschr       Date:  2007

Review 9.  Laboratory diagnostics of invasive fungal infections: an overview with emphasis on molecular approach.

Authors:  Lenka Bašková; Vladimír Buchta
Journal:  Folia Microbiol (Praha)       Date:  2012-05-08       Impact factor: 2.099

Review 10.  Evidence-based guidelines for empirical therapy of neutropenic fever in Korea.

Authors:  Dong-Gun Lee; Sung-Han Kim; Soo Young Kim; Chung-Jong Kim; Wan Beom Park; Young Goo Song; Jung-Hyun Choi
Journal:  Korean J Intern Med       Date:  2011-06-01       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.